Comparison

KZR-504 European Partner

Item no. HY-101786-25mg
Manufacturer MedChem Express
CASRN 1629052-78-3
Amount 25 mg
Quantity options 100 mg 10 mg 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.12
Formula C21H23N3O6
Citations [1]Johnson HWB, et al. Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit. ACS Med Chem Lett. 2017 Mar 9;8(4):413-417.
Smiles O=C(N[C@@H](CO)C(N[C@@H](CC1=CC=CC=C1)C([C@]2(CO2)C)=O)=O)C(N3)=CC=CC3=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 1629052-78-3
Similar products 1629052-78-3
Available
Product Description
KZR-504 is a highly selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2), with IC50s of 51 nM, 4.274 μM for LMP2 and LMP7, respectively. KZR-504 is of interest for the treatment of autoimmune disease[1].
StorageTemperature
-20°C (Powder, protect from light, stored under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
413.42
Clinical Information
No Development Reported
Manufacturers Research Area
Inflammation/Immunology
Solubility
DMSO : 100 mg/mL (ultrasonic)
Target
Proteasome
Manufacturers Target
Proteasome
Manufacturers Pathway
Metabolic Enzyme/Protease
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close